These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8796577)

  • 1. Contrast agent pharmacokinetics revisited: I. Reformulation.
    Dawson P; Blomley MJ
    Acad Radiol; 1996 Aug; 3 Suppl 2():S261-3. PubMed ID: 8796577
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast agent pharmacokinetics revisited: II. Computer-aided analysis.
    Blomley MJ; Dawson P
    Acad Radiol; 1996 Aug; 3 Suppl 2():S264-7. PubMed ID: 8796578
    [No Abstract]   [Full Text] [Related]  

  • 3. Iopromide-carrying liposomes as a contrast agent for the liver.
    Krause W; Leike J; Schuhmann-Giampieri G; Sachse A; Schmiedl U; Strunk H
    Acad Radiol; 1996 Aug; 3 Suppl 2():S235-7. PubMed ID: 8796571
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional computed tomography scanning with radiopaque agents: applications in the brain, kidney, and tumor of small and large mammals.
    Wolf GL; Gazelle GS; Hamberg L; Hunter G; Rogowska J; Jiang D; Leong F
    Acad Radiol; 1996 Aug; 3 Suppl 2():S376-8. PubMed ID: 8796607
    [No Abstract]   [Full Text] [Related]  

  • 5. Human pharmacokinetics and modeling of the concentration-attenuation relationship of a new liposomal liver-specific contrast agent for CT.
    Höglund P; Leander P; Hustvedt SO; Kloster Y; Børseth A
    Acad Radiol; 1998 Apr; 5 Suppl 1():S47-8; discussion S60-2. PubMed ID: 9561041
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of normal and cancerous lymph nodes on indirect computed tomography lymphographic studies after interstitial injection of iodinated nanoparticles.
    Wisner ER; Katzberg RW; Griffey SM; Haley PJ; Johnson DK; Vessey AR
    Acad Radiol; 1996 Aug; 3 Suppl 2():S257-60. PubMed ID: 8796576
    [No Abstract]   [Full Text] [Related]  

  • 7. [Perfusion MR imaging of the liver with a vascular contrast agent].
    Leporq B; Beuf O; Pilleul F
    J Radiol; 2011 Mar; 92(3):257-61. PubMed ID: 21501767
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast media clearance in a single kidney measured on multiphasic helical CT: results in 50 patients without acute renal disorder.
    Hackstein N; Cengiz H; Rau WS
    AJR Am J Roentgenol; 2002 Jan; 178(1):111-8. PubMed ID: 11756102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of contrast media in humans: model with circulation, distribution, and renal excretion.
    Lawaczeck R; Jost G; Pietsch H
    Invest Radiol; 2011 Sep; 46(9):576-85. PubMed ID: 21654496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dy-EOB-DTPA: tolerance and pharmacokinetics in healthy volunteers and preliminary liver imaging in patients.
    Krause W; Mahler M; Hanke B; Milius W; Kaufmann J; Rogalla P; Hamm B
    Invest Radiol; 2001 Aug; 36(8):431-44. PubMed ID: 11500593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echogenicity of sonographic contrast media at variable shear rates and concentrations.
    Kallio T; Alanen A; Bondestam S
    Acad Radiol; 1996 Aug; 3 Suppl 2():S312-4. PubMed ID: 8796589
    [No Abstract]   [Full Text] [Related]  

  • 12. Extrarenal plasma clearance of iohexol and other markers of normal and reduced glomerular filtration rate.
    Almén T; Frennby B; Sterner G; Chai CM; Jönsson BA; Månsson S
    Acad Radiol; 1996 Aug; 3 Suppl 2():S254-6. PubMed ID: 8796575
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
    Scholz P; Weinmann HJ; Mützel W; Staks T
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral contrast medium extravasation after coronary angioplasty].
    Foltys H; Krings T; Block F
    Nervenarzt; 2003 Oct; 74(10):892-5. PubMed ID: 14551695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
    Jost G; Pietsch H; Grenacher L
    Invest Radiol; 2013 Oct; 48(10):715-21. PubMed ID: 23666093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of iohexol clearance to determine the glomerular filtration rate. A comparison between different clearance techniques in man and animal.
    Frennby B
    Scand J Urol Nephrol Suppl; 1997; 182():1-63. PubMed ID: 9167229
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and pharmacokinetics of BR21, a liver-specific CT agent, in healthy volunteers.
    Spinazzi A; Ceriati S; Lorusso V; Pianezzola P; Zaccarini P; Fouillet X
    Acad Radiol; 1998 Apr; 5 Suppl 1():S20-2; discussion S28-30. PubMed ID: 9561035
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of plasma clearance of iodixanol during versus after angiography.
    Hu S; Akhlaghi F; Chitnis S; Chiu R; Go S; Rout P; Steffes M; Abbott JD; Dworkin L; Bostom A
    Am J Kidney Dis; 2010 Dec; 56(6):1219-20. PubMed ID: 21094917
    [No Abstract]   [Full Text] [Related]  

  • 19. An overview of the clinical pharmacokinetics of x-ray contrast media.
    Bourin M; Jolliet P; Ballereau F
    Clin Pharmacokinet; 1997 Mar; 32(3):180-93. PubMed ID: 9084958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental enhancement with AF0145, a perfluorocarbon-stabilized microbubble sonographic contrast agent.
    Mattrey RF; Baker KG; Hall LA; Steinbach GC; Peterson T
    Acad Radiol; 1996 Aug; 3 Suppl 2():S320-1. PubMed ID: 8796592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.